References
- Black RE, Cousens S, Johnson HL et al. Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet 375, 1969–1987 (2010).
- Qin HY, Wu JC, Tong XD, Sung JJ, Xu HX, Bian ZX. Systematic review of animal models of post-infectious/post-inflammatory irritable bowel syndrome. J. Gastroenterol. 46, 164–174 (2011).
- Tate JE, Burton A, Boschi-Pinto C, Steele AD, Agocs M, Parashar UD. Global mortality associated with rotavirus disease among children in 2008. Lancet Infect. Dis. 12(2), 136–141 (2012).
- Richardson V, Parashar UD, Patel M. Childhood diarrhea deaths after rotavirus vaccination in Mexico. N. Engl. J. Med. 365, 772–773 (2011).
- WHO. Rotavirus vaccine and intussusception: report from an expert consultation. Wkly Epidemiol. Rec. 86(30), 317–324 (2011).
- Patel M, Richardson V, Bulhões MM et al. Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil. N. Engl. J. Med. 365(24), 2283–2292 (2011).
- Atmar RL, Bernstein DI, Harro CD et al. Norovirus vaccine against experimental human Norwalk Virus illness. N. Engl. J. Med. 365(23), 2178–2187 (2011).
- Harro C, Sack D, Bourgeois AL et al. A combination vaccine consisting of three live-attenuated enterotoxigenic Escherichia coli strains expressing a range of colonization factors and LTB is well tolerated and immunogenic in a placebo-controlled double-blind Phase I trial in healthy adults. Clin. Vaccine Immunol. 18(12), 2118–2127 (2011).
- Harro C, Chakraborty S, Feller A et al. Refinement of a human challenge model for evaluation of enterotoxigenic Escherichia coli vaccines. Clin. Vaccine Immunol. 18(10), 1719–1727 (2011).
- Riddle MS, Kaminski RW, Williams C et al. Safety and immunogenicity of an intranasal Shigella flexneri 2a Invaplex 50 vaccine. Vaccine 29(40), 7009–7019 (2011).
- Theillet FX, Simenel C, Guerreiro C, Phalipon A, Mulard LA, Delepierre M. Effects of backbone substitutions on the conformational behavior of Shigella flexneri O-antigens: implications for vaccine strategy. Glycobiology 21(1), 109–121 (2011).
- Ihssen J, Kowarik M, Dilettoso S, Tanner C, Wacker M, Thöny-Meyer L. Production of glycoprotein vaccines in Escherichia coli. Microb. Cell Fact. 11(9), 61 (2010).
- Nelson CB, de Quadros C. Coalition against Typhoid (CaT): a new, global initiative to advance typhoid vaccination. Vaccine 29(38), 6443 (2011).
- Bhutta ZA, Khan MI, Soofi SB, Ochiai RL. New advances in typhoid fever vaccination strategies. Adv. Exp. Med. Biol. 697, 17–39 (2011).
- van Damme P, Kafeja F, Anemona A et al. Safety, immunogenicity and dose ranging of a new Vi-CRM197 conjugate vaccine against typhoid fever: randomized clinical testing in healthy adults. PLoS One 6(9), e25398 (2011).
Website
- The interactions of malnutrition and enteric infections (MAL-ED): consequences for child health and development. http://mal-ed.fnih.org